Doctor and pharmacy shopping for controlled substances

Medical Care

Volumn 50, Issue 6, 2012, Pages 494-500

  Peirce, Gretchen L ^a,c   Smith, Michael J ^a,c   Abate, Marie A ^a   Halverson, Joel ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Doctor shopping; Drug related death; Pharmacy shopping; Prescription monitoring programs

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; OPIATE; PRESCRIPTION DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CONTROLLED STUDY; DOCTOR SHOPPING; DRUG ABUSE; DRUG MARKETING; DRUG MISUSE; DRUG MONITORING; DRUG OVERDOSE; HEALTH CARE UTILIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PHARMACY; PHARMACY SHOPPING; PHYSICIAN; PRESCRIPTION; PRESCRIPTION DRUG ABUSE; PRESCRIPTION MONITORING PROGRAM; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGE FACTORS; AGED; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG-SEEKING BEHAVIOR; HUMANS; MIDDLE AGED; OVERDOSE; PHARMACIES; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS; WEST VIRGINIA;

EID: 84862799792     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31824ebd81     Document Type: Article

References (34)

1. McCabe SE, Cranford JA, West BT. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav. 2008;33:1297-1305.
2. McCabe SE, West BT, Wechsler H. Trends and college-level characteristics associated with the non-medical use of prescription drugs among US college students from 1993 to 2001. Addiction. 2007;102:455-465. (Pubitemid 46239372)
3. Simoni-Wastila L, Strickler G. Risk factors associated with problem use of prescription drugs. Am J Public Health. 2004;94:266-268. (Pubitemid 38176324)
4. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15:618-627. (Pubitemid 44404658)
5. Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710-1714. (Pubitemid 30196211)
6. Paulozzi LJ, Jones CM, Mack KA, et al. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR. 2011;60:1-6.
7. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300: 2613-2620.
8. Department of Health and Human Services. Overview of findings from 2003 National Survey on Drug Use and Health. 2004. Available at: http://www.oas. samhsa.gov/nhsda/2k3nsduh/2k3Overview.htm#toc. Accessed June 16, 2011.
9. Califano J. Under The Counter. The Diversion and Abuse of Controlled Prescription Drugs in the US. New York, NY: The National Center on Addiction and Substance Abuse at Columbia University (CASA); 2005.
10. Office of Applied Studies. The NSDUH Report: patterns and trends in nonmedical prescription pain reliever use: 2002-2005. Available at: http://www.oas.samhsa.gov/2k7/pain/pain.htm. Accessed June 16, 2011.
11. Maxwell JC. Trends in the abuse of prescription drugs. The Center for Excellence in Drug Epidemeiology, The Gulf Coast Addiction Technology Transfer Center, The University of Texas at Austin. 2006. Available at:http://asi.nattc. org/userfiles/file/GulfCoast/PrescriptionTrends-Web.pdf. Accessed June 16, 2011.
12. Office of Applied Studies. State estimates of substance use and mental health from the 2005-2006 National Surveys on Drug Use and Heath, West Virginia state profile. Available at:http://oas.samhsa.gov/2k6State/WestVirginia.htm. Accessed June 16, 2011.
13. Martyres RF, Clode D, Burns JM. Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. Med J Aust. 2004;180:211-214. (Pubitemid 38312981)
14. Spillane J, McAllister WB. Keeping the lid on: a century of drug regulation and control. Drug Alcohol Depend. 2003;70:S5-S12. (Pubitemid 36577512)
15. Manchikanti L, Brown KR, Singh V. National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity. Pain Physician. 2002;5:294-319.
16. Barrett K, Watson A. Physician perspectives on a pilot prescription monitoring program. JPain Palliat Care Pharmacother. 2005;19: 5-13. (Pubitemid 41667117)
17. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA. 2007;297:249-251. (Pubitemid 46143290)
18. Inciardi JA, Surratt HL, Kurtz SP, et al. Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Med. 2007;8:171-183.
19. Caulkins JP. How prevalent are "very light" drug users? Federation Am Scientists' Drug Policy Analysis Bull. 1997;3:3-5.
20. Fischer B, Rehm J, Patra J, et al. Changes in illicit opioid use across Canada. CMAJ. 2006;175:1385-1387. (Pubitemid 44876556)
21. Joranson DE, Gilson AM. Drug crime is a source of abused pain medications in the United States. J Pain Symptom Manage. 2005;30: 299-301. (Pubitemid 41527112)
22. Manchikanti L, Pampati V, Damron KS, et al. Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use? Pain Physician. 2004;7:71-75. (Pubitemid 38195756)
23. Hurwitz W. The challenge of prescription drug misuse: a review and commentary. Pain Med. 2005;6:152-161. (Pubitemid 40590529)
24. Klienschmidt R, Price J, Caught K. Doctor shopping. Aust Fam Physician. 1995;24:1037-1041.
25. Pradel V, Thirion X, Ronfle E, et al. Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol Drug Saf. 2004;13:473-481. (Pubitemid 38996858)
26. Feroni I, Peretti-Watel P, Paraponaris A, et al. French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment. J Addict Dis. 2005;24:7-22. (Pubitemid 41542392)
27. Buurma HPD, Bouvy ML, De Smet P, et al. Prevalence and determinants of pharmacy shopping behaviour. J Clin PharmTher. 2008;33:17-23.
28. Katz N, Panas L, Kim ML, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf. 2010;19:115-123.
29. Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-1321.
30. West Virginia State Board of Pharmacy. Governing: The Practice of Pharmacy; Controlled Substance Act. Charleston, WV: Pharmacy Laws and Legislative Rules of West Virginia; 2008.
31. Wilsey BL, Fishman SM, Gilson AM, et al. An analysis of the number of multiple prescribers for opioids using data from the California Prescription Monitoring Program. Pharmacoepidemiol Drug Safety. 2011;20:1262-1268. doi: 10.1002/pds.2129.
32. Swedlow A, Ireland J, Johnson G. Prescribing patterns of Schedule II Opioids in California Workers' Compensation. Available at:http://www. cwci.org/document.php?file = 1438.pdf. Accessed November 2, 2011.
33. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ. 1996;154:1177-1184. (Pubitemid 26143694)
34. Gomes T, Mamdani M, Dhalla I, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686-691.